Who owns RAPT THERAPEUTICS INC?
- Ticker: RAPT
- CUSIP Number: 75382e208
Tip: Access positions for across all investors
Analyze quarterly positions in Rapt Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Rapt Therapeutics stock
Who bought or sold RAPT THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| TCG Crossover Management | 1.6M | $42M | 0% | Sep 2025 |
|
| Foresite Capital Management VI | 1.6M | $40M | 0% | Sep 2025 |
|
| Rtw Investments | 1.5M | $38M | 0% | Sep 2025 |
|
| OrbiMed Advisors | 1.1M | $28M | -34% | Sep 2025 |
|
| Ikarian Capital | 790k | $20M | 100% | Sep 2025 |
|
| Boone Capital Management | 783k | $20M | 100% | Sep 2025 |
|
| Deep Track Capital | 751k | $19M | 0% | Sep 2025 |
|
| Vanguard Group | 696k | $18M | -21% | Sep 2025 |
|
| Nantahala Capital Management | 623k | $16M | -35% | Sep 2025 |
|
| Siren | 581k | $15M | 100% | Sep 2025 |
|
| Redmile Group | 553k | $14M | -12% | Sep 2025 |
|
| Soleus Capital Management | 538k | $14M | 100% | Sep 2025 |
|
| ADAR1 Capital Management | 508k | $13M | -35% | Sep 2025 |
|
| Fcpm Iii Services B.v. | 344k | $8.9M | -22% | Sep 2025 |
|
| Boothbay Fund Management | 288k | $7.4M | 100% | Sep 2025 |
|
| FMR | 248k | $6.4M | 12729% | Sep 2025 |
|
| Perceptive Advisors | 184k | $4.7M | 0% | Sep 2025 |
|
| Invesco | 141k | $2.2M | 100% | Sep 2025 |
|
| Geode Capital Management | 122k | $3.1M | -13% | Sep 2025 |
|
| SummitTX Capital | 92k | $2.4M | 100% | Sep 2025 |
|
| BlackRock | 90k | $2.3M | 0% | Sep 2025 |
|
| Euclidean Capital | 82k | $2.1M | 0% | Sep 2025 |
|
| Velan Capital Investment Management | 80k | $2.1M | 100% | Sep 2025 |
|
| Goldman Sachs Group | 62k | $1.6M | 100% | Sep 2025 |
|
| Ameriprise Financial | 51k | $1.3M | 100% | Sep 2025 |
|
| Balyasny Asset Management | 50k | $1.3M | 100% | Sep 2025 |
|
| Susquehanna International | 45k | $1.2M | 173% | Sep 2025 |
|
| Millennium Management | 39k | $1.0M | 75% | Sep 2025 |
|
| State Street Corporation | 37k | $964k | 96% | Sep 2025 |
|
| Two Sigma Investments | 35k | $898k | -20% | Sep 2025 |
|
| Superstring Capital Management | 34k | $888k | 32% | Sep 2025 |
|
| Renaissance Technologies | 34k | $885k | -45% | Sep 2025 |
|
| Citadel Advisors | 34k | $883k | 137% | Sep 2025 |
|
| UBS Group | 29k | $743k | 680% | Sep 2025 |
|
| Bridgeway Capital Management | 21k | $532k | 32% | Sep 2025 |
|
| Morgan Stanley | 18k | $144k | 100% | Jun 2025 |
|
| Northern Trust | 17k | $439k | -31% | Sep 2025 |
|
| Marshall Wace | 17k | $434k | 100% | Sep 2025 |
|
| Acadian Asset Management | 17k | $432k | -82% | Sep 2025 |
|
| Royal Bank of Canada | 15k | $376k | 0% | Sep 2025 |
|
| HighTower Advisors | 13k | $326k | 100% | Sep 2025 |
|
| Point72 Asset Management | 12k | $319k | 100% | Sep 2025 |
|
| GSA Capital Partners | 11k | $272k | -13% | Sep 2025 |
|
| Charles Schwab Investment Management | 10k | $258k | 0% | Sep 2025 |
|
| Trustees of Columbia University in the City of New York | 9.2k | $237k | 100% | Sep 2025 |
|
| Dimensional Fund Advisors | 8.9k | $230k | 100% | Sep 2025 |
|
| Group One Trading | 2.7k | $70k | 100% | Sep 2025 |
|
| Russell Investments | 1.1k | $28k | 0% | Sep 2025 |
|
| Pnc Financial Services | 497.00 | $13k | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 323.00 | $8.3k | 100% | Sep 2025 |
|
| Banque Cantonale Vaudoise | 154.00 | $7.0k | 100% | Sep 2025 |
|
| CWM | 113.00 | $3.0k | -84% | Sep 2025 |
|
| Barclays | 95.00 | $2.4k | 332% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 79.00 | $2.0k | -41% | Sep 2025 |
|
| NISA Investment Advisors | 79.00 | $2.0k | 0% | Sep 2025 |
|
| Fortitude Family Office | 63.00 | $1.6k | 100% | Sep 2025 |
|
| EverSource Wealth Advisors | 58.00 | $1.5k | 4% | Sep 2025 |
|
| Point72 | 16.00 | $405.000000 | 100% | Sep 2025 |
|
| Bessemer | 11.00 | $0 | 100% | Sep 2025 |
|
| SRS Capital Advisors | 1.00 | $25.000000 | 100% | Sep 2025 |
|
Who sold out of Rapt Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Medicxi Ventures Management | Jun 2025 | 2.8M | $22M |
| BVF | Jun 2025 | 1.2M | $9.2M |
| Two Sigma Advisers | Jun 2025 | 24k | $189k |
| Tower Research Capital | Jun 2025 | 1.9k | $15k |
| Wells Fargo & Company | Jun 2025 | 1.2k | $9.8k |
| Simplex Trading | Jun 2025 | 197.00 | $999.991700 |
| Federated Investors | Jun 2025 | 136.00 | $1.1k |
| Amalgamated Bank | Jun 2025 | 1.00 | $0 |